Biomaterial Partnerships

Jellagen’s mission is to replace mammalian collagen sources with sustainable and biocompatible marine collagen. We have established ourselves as leaders in the marine collagen space through internal research and collaborations with leading academic institutions.

We are open to both academic and industry partnerships with forward-thinking organizations who want to benefit not only from our innovative, new collagen source, but also our expertise.

Our collagen products are manufactured from sustainably harvested R. pulmo jellyfish. Jellagen’s collagen can be classified as Type zero (0) collagen and due to the animal’s ancient lineage shares similarities to Types I, II, III, IV, V and IX. This makes Jellagen’s type 0 collagen an ideal biomaterial for various applications.

Jellagen is ISO13485:2016 certified and work towards GMP (Good Manufacturing Practice) principles. This certification allows partners to have full confidence that Jellagen operates to the highest manufacturing and management standards. Our business integrates every part of the Supply chain, with full control of every aspect of harvesting, manufacturing, R&D and commercial operations.

Our company is ideally suited to partner with companies looking for:

  • An OEM partner: Jellagen manufactures products that are available for private label distribution by our customers.
  • A materials supplier: Jellagen produces raw materials that can be integrated into our customer’s production processes.
  • Customer-specific product development: Jellagen has the expertise to design, develop and manufacture products to meet the specific needs of our customers.

Current Projects

Jellagen is looking for industrial partners to co-develop and launch products in the following areas:

Vocal Cord Paralysis (VCP)

Vocal Cord paralysis is the inability to move the muscles that control the vocal cords and is caused by injury to one or both recurrent laryngeal nerves (RLNs), which control most of the muscles of the larynx. The RLN is important for speaking, breathing and swallowing. Vocal Cord Paralysis occurs when the nerve impulses of the larynx are disrupted. This results in paralysis of the vocal cord muscles.

The global Vocal Cord Paralysis market is estimated at $2.6 Billion in 2020 and we have identified a $380 million addressable market for our developmental product.

Wound Management

Chronic wounds are classified as wounds that do not heal within a reasonable period (3 months). Not only do these wounds present a substantial economic burden to national healthcare systems; they also significantly reduce quality of life for those affected, and often precede serious events such as limb amputations or even premature deaths. This burden is also likely to increase with a larger proportion of elderly and increasing prevalence of life-style diseases such as obesity and diabetes.

Management of chronic wounds therefore tends to take place within primary care and presents a challenge for both healthcare professionals and patients alike (Dowsett et al, 2014; Murray, 2019). These painful, often debilitating wounds cause severe physical and emotional stress to patients and have been estimated to cost the NHS £3.2 billion per annum [Guest el al, 2015; Guest et al, 2017].  In the United States alone, these wounds affect an estimated 2.4–4.5 million people [Brownrigg J.R et. al. 2015].

We have identified an addressable market of $600 Million for our developmental product.

For more information on partnering with Jellagen, please contact us.

Benefits of Marine Type 0 Collagen

  • Provides an inert and biocompatible tissue engineering scaffold
  • Batch to batch consistent
  • Non-mammalian
  • Cleaner at the microRNA level
  • Disease and viral vector free
  • Excellent handling and conformability
  • Engineered with defined mechanical strength, porosity, and degradation rate
  • Manufactured to ISO13485:2016 & GMP Principles

Manufacturing Expertise

  • Liquid biomaterials
  • Porous matrices
  • Flowable formations
  • Molded shapes
  • Custom shapes and sizes available
  • Manufactured to ISO13485:2016 & GMP Principles

Collagen Technology

Bioengineering with Marine Type 0 Collagen.

Jellagen controls the physical and chemical composition to ensure each product is designed with attributes critical for biological/physiological activity.

Pore Size: Jellagen offers a single pore size range as part of its standard offering, but are able to work with customers to tailor the pore size they require.

Crosslinking: Jellagen offers a biocompatible material that can be crosslinked with a range of agents.

Degradation Rate: Jellagen has developed materials with varying degrees of degradation as required by different product profiles.


  • General hemostasis
  • Wound healing
  • Sports medicine
  • Dental surgery
  • Soft tissue repair
  • Bone regeneration (Flaig et al. 2020)

Customer applications available